ArticleFrontiers in pharmacology2023

Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmacokinetic/pharmacodynamic analysis.

Junzhen Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.